Overall 5-year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection

International Journal of Gynecological Cancer

Volumn 10, Issue 4, 2000, Pages 305-312

  Kim, S M ^a   Choi, H S ^a   Byun, J S ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

5 year overall survival rate; Adjuvant therapy; Cervical cancer; Prognostic factor; Radical hysterectomy

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER RISK; CANCER SIZE; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; RADICAL HYSTERECTOMY; SURVIVAL RATE; UTERINE CERVIX CARCINOMA;

EID: 0033813382     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2000.010004305.x     Document Type: Article

References (69)

1. Estimates of the worldwide incidence of eighteen major cancers in 1985
2. Role of cytology in cervical cancer
3. Trends in survival rates of patients with cancer
4. Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early stage sqamous carcinoma of the cervix
5. Prognostic factors associated with radical hysterectomy failure
6. Patterns of recurrence of carcinoma following radical hysterectomy
7. Identification of histopathologic risk groups in the stage IB squamous cell carcinoma of cervix
8. Prognostic factors in stage IB squamous cervical cancer patients with low risk for recurrence
9. Radical hysterectomy for early invasive cervical cancer: A 25-year prospective experience with the Miami technique
10. Local spread and lymph node involvement in cervical cancer
11. Lymph node metastasis from carcinoma of the cervix Stage IB and IIA. Implications for prognosis and treatment
12. V factor (tumor volume) and T factor (FIGO classification) in the assessment of cervical prognosis: The risk of lymph node spread
13. Radical hysterectomy as therapy for early carcinoma of the cervix
14. Prognostic factors and operative treatment of stage IB to IIB cervical cancer
15. Staging laparotomy and radical hysterectomy for cancer of cervix
16. Prognostic factors for risk of recurrence in stage IB and IIA cervical cancer
17. Prospective surgical-pathological study of disease-free interval in patients with Stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
18. Influence of histological feature and treatment on the prognosis of patients with cervical cancer metastatic to pelvic lymph nodes
19. The prognostic significance of number of positive nodes in cervical carcinoma Stage IB, IIA and IIB
20. Multivariate analysis of histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy
21. Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for Stage IB and IIA carcinoma of the cervix
22. Treatment of cervical cancer: A randomized study of operation and radiation
23. Radical hysterectomy or radiotherapy for stage I cervical cancer: Aprospective comparison with five and ten year follow-up
24. Radical pelvic surgery versus radiation therapy for stage I carcinoma of the cervix exclusive of microinvasion
25. Prognostic factors in stage IB sqamous cervical cancer patients with low risk for recurrence
26. Prognostic factors of early stage cervical cancer treated by radical hysterectomy
27. Operative treatment of carcinoma of the cervix
28. Carcinoma of the cervix: Attempt to individualize treatment. Result of a 20-year cooperative study
29. Surgical treatment in 561 cases and study on 15,092 cases of carcinoma of the uterine cervix: Review of 20 years experience, from 1963 to 1983
30. Clinical profile and 5-year survival rate of uterine cervical cancer
31. Adjuvant radiochemotherapy following radical hysterectomy of patients with Stage IB and IIA cervical cancer
32. Is there a role for adjuvant pelvic radiotherapy after radical hysterectomy in early stage cervical cancer?
33. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in treatment of Stage IB and IA cervical carcinoma
34. Early cervical carcinoma: Are two treatments better than one?
35. Adjuvant chemotherapy after radical hysterectomy for cervical cancer
36. A pilot study of adjuvant therapy in patients with cervical cancer at risk of recurrence after radical hysterectomy
37. Youth as a prognostic factor in carcinoma of the cervix: A matched analysis
38. Age, substance abuse, and survival of patients with cervical carcinoma
39. Survival trend after invasive cervical cancer diagnosis in Sweden before and after cytologic screening
40. Survival of advanced age females with cervical carcinoma
41. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan
42. The continuing increase in adenocarcinoma of the uterine cervix: A birth cohort phenomenon
43. The presentation of adenocarcinoma of the uterine cervix cancer
44. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix
45. Recurrence and survival analyses of 1,115 cervical cancer patients treated with radical hysterectomy
46. Oral contraceptive use and adenocarcinoma of cervix
47. Radical hysterectomy for Stage IB adenocarcinoma of the cervix: The University of Miami experience
48. Adenosquamous carcinoma of the cervix: Prognosis in early stage disease treated by radical hysterectomy
49. Radical surgery for Stage IB adenosquamous cell carcinoma of the cervix: A matched study of outcome
50. Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma. MIB-1 and PC10 labelling indices
51. Prognostic factors of adenocarcinoma of the uterine cervix
52. Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma
53. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
54. Randomized study of radical surgery versus radiotherapy for stage IB-IIA cervical cancer
55. Patients with squamous cell versus aseno (squamous) carcinoma of the cervix, what factors determine the prognosis?
56. Prognostic factors in patients with locally advanced cervical cancer treated with radical hysterectomy and adjuvant radiotherapy
57. Operative therapy for Stage IB cervical cancer
58. Pelvic and parametrial lymph nodes in quality control of the surgical treatment of cervical cancer
59. Stage IB carcinoma of the cervix, the Norwegian Radium Hospital. Results when pelvic nodes are involved
60. Stage IB carcinoma of the cervix with lymph node metastases
61. Treatment of carcinoma of the cervix by combination of irradiation and operation
62. Pretreatment surgical staging in cervical carcinoma: Therapeutic efficacy of pelvic lymph node resection
63. The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: Correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen
64. Prognostic significance of tumor emboli in lymphatics or vascular spaces of the cervical stroma in stage IB sqamous cell carcinoma of the cervix
65. The prognostic significance of vascular channel involvement and deep stromal penestration in early cervical cancer
66. Prognostic factors in adenocarcinoma of the uterine cervix
67. Radical hysterectomy for stage IB1 vs. IB2 carcinoma of the cervix: Does the new staging system predict morbidity and survival?
68. FIGO news. Modification in the staging for stage I vulvar and stage I cervical cancer